Developer docs
API playgroundTry for free, no card

Search company profiles

Eucare Pharmaceuticals

Full company profile

uuid000s5db

Namestring
Eucare Pharmaceuticals
Legal namestring
Eucare Pharmaceuticals (P) Ltd.
Websiteurl
eucareindia.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Eucare Pharmaceuticals (P) Ltd. is a privately held bio-pharmaceutical company incorporated in 1996 and headquartered in Chennai, Tamil Nadu, India. The company specializes in collagen-based medical devices and drug delivery systems, operating across five therapeutic categories: burns, wound care, surgical haemostasis, dental fillers and regeneration, and scar management. Its product portfolio includes bovine-based, fish-origin, and porcine-origin collagen membranes, particles and sponges (Kollagen, NeuSkin, BioFil, BioFil-AB, BioFil Sponge, GelSpon, Scrofalon), a silicone-based scar gel (Lysil), a collagen periodontal membrane (PerioCol-GTR), and synthetic nanocrystalline hydroxyapatite bone grafts (SyboGraf, SyboGraf-Plus). The company leverages TLC Technology — a patented jellified healing matrix licensed from Laboratoires Urgo — as the foundation of its advanced wound care solutions, and additionally distributes Laboratoires Urgo's medical product line in India under the 'Urgo Medical India' sub-brand.

Eucare generates revenue through direct sales of its medical device and pharmaceutical products via three primary channels: a domestic sales and government tender motion, an export and Own Brand Label (OBL) business for international markets, and an IndiaMART marketplace listing. Products are sold to hospitals, burn centers, dental clinics, surgical centers, and healthcare professionals treating burns, chronic wounds, infected sites, surgical bleeding, periodontal defects, and scars. Certain products are CE-marked (e.g., Scrofalon in the EU), while trademarks span India and EU jurisdictions, reflecting an attempt to commercialize in regulated export markets.

The company is founder or privately held, with no disclosed external funding rounds, institutional investors, or public listing. The leadership team includes Managing Director S. Sridharan, and headcount is reported at 1-10 employees. There is no publicly disclosed revenue figure, and no management team beyond the managing director is named in the available sources. Distribution relies on dedicated email and phone contacts for each sales motion rather than a large field sales force, suggesting a lean operating model where manufacturing and partnership-licensed technology (Urgo TLC) carry the technical burden.

Short descriptiontext

Eucare Pharmaceuticals (P) Ltd., founded 1996 in Chennai, India, is a private bio-pharmaceutical company that develops and sells collagen-based medical devices for burns, wound care, surgical haemostasis, dental regeneration, and scar management to healthcare facilities domestically and for export.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
collagen medical devices, wound care products, burn treatment membranes, surgical haemostatic agents, dental bone grafts
Industry3 codes
PRIMARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHALAA
Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Collagen-based Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device/Pharmaceutical Product Sales
TypeOne Time License
Description

Eucare generates revenue through the sale of collagen-based medical devices and pharmaceutical products including burn treatments, wound care products, surgical haemostats, dental fillers, and scar management products. Products are sold domestically, through tenders, and for export.

eucareindia.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Urgo Medical India
Description

Partnership/distribution relationship with Laboratoires Urgo for medical products in India market.

eucareindia.com
Core offering1 text field

Eucare Pharmaceuticals manufactures and sells collagen-based medical devices and drug delivery products for burn treatment, advanced wound care, surgical haemostasis, dental bone grafting/regeneration, and scar management. The portfolio covers collagen membranes (Kollagen, NeuSkin, Kollagen-D, PerioCol-GTR), collagen particles and sponges (BioFil, BioFil-AB, BioFil Sponge), haemostatic gelatin sponges (GelSpon, Scrofalon), synthetic and biphasic bone grafts (SyboGraf, SyboGraf-Plus), and silicone gel sheets (Lysil/Lysil-Gel). Products are sold directly to hospitals, clinics and surgical centers domestically, through government tenders, via exports/OBL, and through the IndiaMART B2B marketplace.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Eucare Pharmaceuticals is a Bio-Pharmaceutical company incorporated in 1996 from Chennai, India, specializing in Collagen technologies and Drug delivery systems. Their product portfolio is organized into five therapeutic categories: Burns (Kollagen®, NeuSkin™, Kollagen®-D), WoundCare (BioFil®, BioFil®-AB, BioFil® Sponge), Scar Management (Lysil™), Haemostat (GelSpon®, Scrofalon®), and Dental (PerioCol®-GTR, SyboGraf®, SyboGraf®-Plus). The company leverages proprietary TLC Technology licensed from Laboratoires Urgo, which forms the foundation of their advanced wound care solutions. Their products are distributed under various brand architectures including Kollagen®, BioFil®, NeuSkin™, Lysil™, GelSpon®, Scrofalon®, PerioCol®-GTR, and SyboGraf® brands.

Product and service12 records
1Kollagen
CategoryBurn treatment - collagen membrane
Description

Bovine-based extracellular matrix native collagen membrane that acts as a skin substitute for treating superficial and deep dermal burns in a cost-effective way. Targeted at hospitals and burn centers.

2NeuSkin
CategoryBurn treatment - collagen membrane
Description

Collagen membrane for burn treatment, offered in freeze-dried form to avoid pre-treatment in normal saline before application, gamma sterilized and available in different dimensions. Used by hospitals and burn units.

3Kollagen-D
CategoryBurn treatment - collagen dressing
Description

Sterile porous collagen dressing made from intact Type 1 collagen of fish origin with a porous matrix structure combined with a nylon mesh layer. Used as primary collagen dressing for partial thickness burns and wounds and as a matrix for tissue regeneration. Targeted at hospitals and burn centers.

4BioFil
CategoryWound care - collagen particles
Description

Sterile collagen particles used for treating various wounds including acute chronic ulcers and diabetic ulcers. Used by hospitals and wound care clinics.

5BioFil-AB
CategoryWound care - medicated collagen particles
Description

Sterile medicated collagen particles impregnated with mupirocin USP 2% w/w and metronidazole IP 1% w/w, used for treating difficult and chronic wound conditions and grossly infected sites. Targeted at hospitals and wound care clinics.

6BioFil Sponge
CategoryWound care - collagen sponge
Description

Sterile collagen sponge used for treating cavity wounds, exuding wounds and venous stasis ulcers. Used by hospitals and wound care clinics.

7Lysil & Lysil-Gel
CategoryScar management - silicone gel sheet
Description

Silicone gel sheet composed of soft, semi-occlusive polysiloxane material with excellent biocompatibility. Used for scar management by promoting hydration of stratum corneum to flatten and fade scars. Used by hospitals, burn centers and dermatology/plastic surgery clinics.

8GelSpon
CategorySurgical haemostat - gelatin sponge (bovine)
Description

Sterile absorbable haemostatic gelatin sponges manufactured from highly purified gelatin material from bovine origin. Used in various surgical procedures where traditional haemostasis is difficult or impractical. Used by hospitals and surgical centers.

9Scrofalon
CategorySurgical haemostat - gelatin sponge (porcine, CE marked)
Description

Sterile absorbable haemostatic gelatin sponges manufactured from highly purified gelatin material exclusively from porcine origin. Used in various surgical procedures where traditional haemostasis is difficult or impractical. Used by hospitals and surgical centers.

10PerioCol-GTR
CategoryDental - guided tissue regeneration membrane
Description

Type 1 collagen membrane of fish origin for Guided Tissue Regeneration (GTR) applications with excellent handling characteristics and cost effectiveness. Used by dental clinics and periodontal specialists.

11SyboGraf
CategoryDental - synthetic bone graft material
Description

Sterile synthetic nanocrystalline Hydroxyapatite bone graft material synthetically prepared using a novel patented biomimetic process technology in powder/granule form. Used by dental clinics, oral surgeons and bone grafting specialists.

12SyboGraf-Plus
CategoryDental - biphasic bone graft composite
Description

Biphasic bone graft composite prepared in-situ combining 70% Hydroxyapatite and 30% Beta-tricalcium phosphate. The faster resorption of Beta-TCP helps in bone mineralization while Hydroxyapatite provides scaffold for calcification. Used by dental clinics and oral surgeons.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Eucare has a partnership with Laboratoires Urgo for access to TLC Technology - an exclusive innovation patented by Laboratoires Urgo. TLC healing matrix is a jellified healing matrix of hydrocolloid, fatty particles and polymers that promotes optimized wound healing. This technology is the core of all Urgo Medical products and is compatible with different materials including contact layer, fibres, and can be associated with compounds such as NOSF or silver. Eucare also distributes Urgo Medical products in India under the 'Urgo Medical India' brand.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

U.S. regenerative medicine company specializing in bioactive and acellular biomaterial products for wound care and surgical applications. Comparable as a specialist in biologic skin/wound healing technologies.

TypeEmerging player
Description

U.S. company commercializing placental tissue allografts and regenerative wound care products. Comparable in the skin substitute and biologic wound healing space.

TypeBroad incumbent
Description

Global medical device company with a sizable Advanced Wound Management division. Directly comparable in collagen/skin substitute and advanced wound dressing categories.

TypeBroad incumbent
Description

Swedish wound care and surgical solutions company with significant presence in advanced wound dressings. Comparable in the wound care and surgical hemostasis categories where Eucare competes.

TypeBroad incumbent
Description

U.S. medical device company with a dedicated regenerative tissue technology portfolio including collagen-based dermal matrices and wound care. Highly comparable to Eucare's collagen membrane and skin substitute products.

TypeRegional player
Description

Indian medical device company with a portfolio covering wound care, surgical sutures, and orthopedics. Comparable as an India-based specialty medical device manufacturer targeting both domestic and export markets.

TypeBroad incumbent
Description

French global wound care major and Eucare's strategic technology partner. Directly comparable as a collagen/advanced wound care company, and the licensor of the TLC Technology that underpins a number of Eucare's products.

TypeBroad incumbent
Description

Global wound care, ostomy, and continence care major. Competes with Eucare in advanced wound dressings and skin substitutes from an international scale.

TypeBroad incumbent
Description

Danish multinational focused on wound care, ostomy, and skin substitutes. Comparable as a major player in advanced wound care and skin regeneration products.

TypeBroad incumbent
Description

Global diversified healthcare major with a substantial wound care and skin health portfolio (including the legacy KCI negative pressure wound therapy franchise). Comparable in advanced wound dressings and burn care.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eucare Pharmaceuticals

Collagen-based Medical Deviceseucareindia.com

Eucare Pharmaceuticals (P) Ltd., founded 1996 in Chennai, India, is a private bio-pharmaceutical company that develops and sells collagen-based medical devices for burns, wound care, surgical haemostasis, dental regeneration, and scar management to healthcare facilities domestically and for export.

What Eucare Pharmaceuticals does

Eucare Pharmaceuticals (P) Ltd. is a privately held bio-pharmaceutical company incorporated in 1996 and headquartered in Chennai, Tamil Nadu, India. The company specializes in collagen-based medical devices and drug delivery systems, operating across five therapeutic categories: burns, wound care, surgical haemostasis, dental fillers and regeneration, and scar management. Its product portfolio includes bovine-based, fish-origin, and porcine-origin collagen membranes, particles and sponges (Kollagen, NeuSkin, BioFil, BioFil-AB, BioFil Sponge, GelSpon, Scrofalon), a silicone-based scar gel (Lysil), a collagen periodontal membrane (PerioCol-GTR), and synthetic nanocrystalline hydroxyapatite bone grafts (SyboGraf, SyboGraf-Plus). The company leverages TLC Technology — a patented jellified healing matrix licensed from Laboratoires Urgo — as the foundation of its advanced wound care solutions, and additionally distributes Laboratoires Urgo's medical product line in India under the 'Urgo Medical India' sub-brand.

Eucare generates revenue through direct sales of its medical device and pharmaceutical products via three primary channels: a domestic sales and government tender motion, an export and Own Brand Label (OBL) business for international markets, and an IndiaMART marketplace listing. Products are sold to hospitals, burn centers, dental clinics, surgical centers, and healthcare professionals treating burns, chronic wounds, infected sites, surgical bleeding, periodontal defects, and scars. Certain products are CE-marked (e.g., Scrofalon in the EU), while trademarks span India and EU jurisdictions, reflecting an attempt to commercialize in regulated export markets.

The company is founder or privately held, with no disclosed external funding rounds, institutional investors, or public listing. The leadership team includes Managing Director S. Sridharan, and headcount is reported at 1-10 employees. There is no publicly disclosed revenue figure, and no management team beyond the managing director is named in the available sources. Distribution relies on dedicated email and phone contacts for each sales motion rather than a large field sales force, suggesting a lean operating model where manufacturing and partnership-licensed technology (Urgo TLC) carry the technical burden.

Eucare Pharmaceuticals firmographics

Firmographics
Name
Eucare Pharmaceuticals
Legal name
Eucare Pharmaceuticals (P) Ltd.
Website
https://eucareindia.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
1–10 employees
Short description
Eucare Pharmaceuticals (P) Ltd., founded 1996 in Chennai, India, is a private bio-pharmaceutical company that develops and sells collagen-based medical devices for burns, wound care, surgical haemostasis, dental regeneration, and scar management to healthcare facilities domestically and for export.
Ownership category
akta.pro rank

Eucare Pharmaceuticals industry classification

Industry
Product category
Collagen-based Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
SECONDARYHLAAAGAG
Wound Healing & Skin Regeneration (advanced dressings, skin substitutes)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAHALAA
Advanced Wound Dressings (Foam, Hydrocolloid, Alginate, Hydrogel, Film)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products

Keywords

  • Collagen medical devices
  • Wound care products
  • Burn treatment membranes
  • Surgical haemostatic agents
  • Dental bone grafts

Where Eucare Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Eucare Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device/Pharmaceutical Product Sales: Eucare generates revenue through the sale of collagen-based medical devices and pharmaceutical products including burn treatments, wound care products, surgical haemostats, dental fillers, and scar management products. Products are sold domestically, through tenders, and for export.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Eucare Pharmaceuticals product offering

Product offering

Core offering

Eucare Pharmaceuticals manufactures and sells collagen-based medical devices and drug delivery products for burn treatment, advanced wound care, surgical haemostasis, dental bone grafting/regeneration, and scar management. The portfolio covers collagen membranes (Kollagen, NeuSkin, Kollagen-D, PerioCol-GTR), collagen particles and sponges (BioFil, BioFil-AB, BioFil Sponge), haemostatic gelatin sponges (GelSpon, Scrofalon), synthetic and biphasic bone grafts (SyboGraf, SyboGraf-Plus), and silicone gel sheets (Lysil/Lysil-Gel). Products are sold directly to hospitals, clinics and surgical centers domestically, through government tenders, via exports/OBL, and through the IndiaMART B2B marketplace.

Product overview

Eucare Pharmaceuticals is a Bio-Pharmaceutical company incorporated in 1996 from Chennai, India, specializing in Collagen technologies and Drug delivery systems. Their product portfolio is organized into five therapeutic categories: Burns (Kollagen®, NeuSkin™, Kollagen®-D), WoundCare (BioFil®, BioFil®-AB, BioFil® Sponge), Scar Management (Lysil™), Haemostat (GelSpon®, Scrofalon®), and Dental (PerioCol®-GTR, SyboGraf®, SyboGraf®-Plus). The company leverages proprietary TLC Technology licensed from Laboratoires Urgo, which forms the foundation of their advanced wound care solutions. Their products are distributed under various brand architectures including Kollagen®, BioFil®, NeuSkin™, Lysil™, GelSpon®, Scrofalon®, PerioCol®-GTR, and SyboGraf® brands.

Differentiator

Problem solved

Functional benefit

Brands

  • Urgo Medical India: Partnership/distribution relationship with Laboratoires Urgo for medical products in India market.

Products and services

  • Kollagen Bovine-based extracellular matrix native collagen membrane that acts as a skin substitute for treating superficial and deep dermal burns in a cost-effective way. Targeted at hospitals and burn centers.
  • NeuSkin Collagen membrane for burn treatment, offered in freeze-dried form to avoid pre-treatment in normal saline before application, gamma sterilized and available in different dimensions. Used by hospitals and burn units.
  • Kollagen-D Sterile porous collagen dressing made from intact Type 1 collagen of fish origin with a porous matrix structure combined with a nylon mesh layer. Used as primary collagen dressing for partial thickness burns and wounds and as a matrix for tissue regeneration. Targeted at hospitals and burn centers.
  • BioFil Sterile collagen particles used for treating various wounds including acute chronic ulcers and diabetic ulcers. Used by hospitals and wound care clinics.
  • BioFil-AB Sterile medicated collagen particles impregnated with mupirocin USP 2% w/w and metronidazole IP 1% w/w, used for treating difficult and chronic wound conditions and grossly infected sites. Targeted at hospitals and wound care clinics.
  • BioFil Sponge Sterile collagen sponge used for treating cavity wounds, exuding wounds and venous stasis ulcers. Used by hospitals and wound care clinics.
  • Lysil & Lysil-Gel Silicone gel sheet composed of soft, semi-occlusive polysiloxane material with excellent biocompatibility. Used for scar management by promoting hydration of stratum corneum to flatten and fade scars. Used by hospitals, burn centers and dermatology/plastic surgery clinics.
  • GelSpon Sterile absorbable haemostatic gelatin sponges manufactured from highly purified gelatin material from bovine origin. Used in various surgical procedures where traditional haemostasis is difficult or impractical. Used by hospitals and surgical centers.
  • Scrofalon Sterile absorbable haemostatic gelatin sponges manufactured from highly purified gelatin material exclusively from porcine origin. Used in various surgical procedures where traditional haemostasis is difficult or impractical. Used by hospitals and surgical centers.
  • PerioCol-GTR Type 1 collagen membrane of fish origin for Guided Tissue Regeneration (GTR) applications with excellent handling characteristics and cost effectiveness. Used by dental clinics and periodontal specialists.
  • SyboGraf Sterile synthetic nanocrystalline Hydroxyapatite bone graft material synthetically prepared using a novel patented biomimetic process technology in powder/granule form. Used by dental clinics, oral surgeons and bone grafting specialists.
  • SyboGraf-Plus Biphasic bone graft composite prepared in-situ combining 70% Hydroxyapatite and 30% Beta-tricalcium phosphate. The faster resorption of Beta-TCP helps in bone mineralization while Hydroxyapatite provides scaffold for calcification. Used by dental clinics and oral surgeons.

Companies that use Eucare Pharmaceuticals

Customer profile

Segments1 record

Ideal customer profiles2 records

Eucare Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Eucare Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Laboratoires UrgocoreTechnology or IntegrationEucare has a partnership with Laboratoires Urgo for access to TLC Technology - an exclusive innovation patented by Laboratoires Urgo. TLC healing matrix is a jellified healing matrix of hydrocolloid, fatty particles and polymers that promotes optimized wound healing. This technology is the core of all Urgo Medical products and is compatible with different materials including contact layer, fibres, and can be associated with compounds such as NOSF or silver. Eucare also distributes Urgo Medical products in India under the 'Urgo Medical India' brand.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Eucare Pharmaceuticals competitors and assessment

Company assessment

Emerging players

  • Organogenesis: U.S. regenerative medicine company specializing in bioactive and acellular biomaterial products for wound care and surgical applications. Comparable as a specialist in biologic skin/wound healing technologies.
  • MiMedx: U.S. company commercializing placental tissue allografts and regenerative wound care products. Comparable in the skin substitute and biologic wound healing space.

Broad incumbents

  • Smith & Nephew: Global medical device company with a sizable Advanced Wound Management division. Directly comparable in collagen/skin substitute and advanced wound dressing categories.
  • Mölnlycke Health Care: Swedish wound care and surgical solutions company with significant presence in advanced wound dressings. Comparable in the wound care and surgical hemostasis categories where Eucare competes.
  • Integra LifeSciences: U.S. medical device company with a dedicated regenerative tissue technology portfolio including collagen-based dermal matrices and wound care. Highly comparable to Eucare's collagen membrane and skin substitute products.
  • Laboratoires Urgo: French global wound care major and Eucare's strategic technology partner. Directly comparable as a collagen/advanced wound care company, and the licensor of the TLC Technology that underpins a number of Eucare's products.
  • ConvaTec: Global wound care, ostomy, and continence care major. Competes with Eucare in advanced wound dressings and skin substitutes from an international scale.
  • Coloplast: Danish multinational focused on wound care, ostomy, and skin substitutes. Comparable as a major player in advanced wound care and skin regeneration products.
  • 3M (Health Care / KCI): Global diversified healthcare major with a substantial wound care and skin health portfolio (including the legacy KCI negative pressure wound therapy franchise). Comparable in advanced wound dressings and burn care.

Regional players

  • Healthium Medtech: Indian medical device company with a portfolio covering wound care, surgical sutures, and orthopedics. Comparable as an India-based specialty medical device manufacturer targeting both domestic and export markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Eucare Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eucare Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Eucare Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eucare Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eucare Pharmaceuticals

What does Eucare Pharmaceuticals do?

Eucare Pharmaceuticals manufactures and sells collagen-based medical devices and drug delivery products for burn treatment, advanced wound care, surgical haemostasis, dental bone grafting/regeneration, and scar management. The portfolio covers collagen membranes (Kollagen, NeuSkin, Kollagen-D, PerioCol-GTR), collagen particles and sponges (BioFil, BioFil-AB, BioFil Sponge), haemostatic gelatin sponges (GelSpon, Scrofalon), synthetic and biphasic bone grafts (SyboGraf, SyboGraf-Plus), and silicone gel sheets (Lysil/Lysil-Gel). Products are sold directly to hospitals, clinics and surgical centers domestically, through government tenders, via exports/OBL, and through the IndiaMART B2B marketplace.

Is Eucare Pharmaceuticals a public or private company?

Eucare Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Eucare Pharmaceuticals founded?

Eucare Pharmaceuticals was founded in 1996. It employs 1 to 10 people.

Where is Eucare Pharmaceuticals based?

Eucare Pharmaceuticals is headquartered in Chennai, India, in the Asia region.

How does Eucare Pharmaceuticals make money?

One revenue line is on record: medical Device/Pharmaceutical Product Sales.

Who are Eucare Pharmaceuticals's main competitors?

Emerging players on record are Organogenesis and MiMedx. Broad incumbents are Smith & Nephew, Mölnlycke Health Care, Integra LifeSciences, Laboratoires Urgo, ConvaTec, Coloplast and 3M (Health Care / KCI). Healthium Medtech is listed as a regional player.

Does Eucare Pharmaceuticals have an API?

No public API is recorded for Eucare Pharmaceuticals.

What industry is Eucare Pharmaceuticals in?

Eucare Pharmaceuticals's product category is Collagen-based Medical Devices. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThe permanent artificial skin market will register a CAGR of almost 19% by 2023Market research firm Technavio projects the global permanent artificial skin market will grow at a compound annual growth rate (CAGR) of approximately 19% by 2023, driven by increasing awareness initiatives around skin and tissue donation and the availability of cost-effective treatments in developing countries. The report identifies the market as fragmented, with key players including Avita Medical, EUCARE PHARMACEUTICALS, Integra LifeSciences, MiMedx, and Solsys Medical competing for market share. Growth challenges include a shortage of diagnostic centers in developing regions where disease burden is high, particularly in parts of South America and Asia-Pacific.PR NewswireHemostat Market: India Industry Analysis and Opportunity Assessment 2016 - 2025Future Market Insights released a 10-year forecast for the India hemostat market, projecting a CAGR of 5.8% over the forecast period (2015-2025), driven by increasing accidents and trauma injuries alongside growing product adoption among healthcare professionals. The mechanical hemostat segment is expected to lead with a 6.0% CAGR, while gelatin-based products currently hold 77.0% market share due to faster blood absorption properties. Key market players identified include Johnson and Johnson (Ethicon), Baxter, Aegis Lifesciences, Eucare Pharmaceuticals, and Mil Laboratories, with hospitals accounting for the highest distribution channel demand at a projected CAGR of 7.0%.